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organism. The failure of liver functions in hepatic cirrho-
sis or for other reasons may thus result in an uncontrolled 
increase in levels of ammonia in the circulating blood. 
Ammonia at high concentrations penetrates from the blood 
into practically all organs. Although the brain is partially 
protected by the blood–brain barrier from toxic agents such 
as ammonia, excessive amounts of ammonia can pass into 
the brain, constituting a principal factor in the syndrome of 
hepatic encephalopathy. In patients, hepatic encephalopathy 
may result from acute liver failure or portal-systemic bypass 
with no intrinsic hepatocellular disease, or may be associ-
ated with cirrhosis and portal hypertension [2], all involving 
enormous costs to society. Ammonia concentrations can be 
experimentally elevated in a variety of ways, e.g., by admin-
istration of hepatotoxins as Professor Jan Albrecht has done 
in his many studies on ammonia toxicity, by peripheral 
administration of massive doses of ammonium chloride, 
or by directing the blood flow from the alimentary canal 
by end-to-side portacaval anastomosis, thus by-passing the 
liver. In addition to this, inborn errors in the urea cycle may 
lead to congenital hyperammonemia.
The brain is much more susceptible to the deleterious 
effects of ammonium during development than in adult-
hood. The concentration of ammonia in the blood is higher 
in newborns than in adults [3]. In the brain the normal 
ammonia content also diminishes during maturation [4]. 
Depending on the extent of hyperammonemia and its dura-
tion, more or less serious irreversible damage is caused to the 
brain, leading to mental retardation [5]. Hyperammonemia 
can provoke irreversible damage to the developing central 
nervous system, which leads to cortical atrophy, ventricular 
enlargement and demyelination, responsible for cognitive 
impairment, seizures and cerebral palsy [6]. An in reased 
exp sure to ammonia during the prenatal and lactation peri-
ods h s been shown to cause long-lasting impairment of 
Abstract Abnormal liver function has dramatic effects on 
brain functions. Hyperammonemia interfer s profoundl  
with brain metabolism, astrocyte volume regulation, a d 
in particular mitochondrial fu ctions. Gene expression in 
the brain and excitatory and inhibitory neurotransmi sion 
circuits are also affected. Exp riments with a num er of 
pertinent animal models have revealed several potential 
mechanisms which could underlie the pathological phe-
nomena occurring in hepatic ncephalopathy.
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Background
Ammonia is produced in the body by intermediary ami o 
acid metabolism or arises from the act ons f intestinal bac-
teria. In human adults approx mately 1000 mmol (17g) of 
ammonia is produced daily [1]. A part of this is reutilized in 
biosynthesis, while the remainde  s waste and neurotoxic. 
Its normal concentration in the portal blo d varies from 300 
to 600 μM, but in the blood leaving the liver the concen-
tration is reduced to 20–60 μM. The liver thus occupies a 
central position in the regulation of ammonia levels in the
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may impair the mitochondrial function in astrocytes second-
arily to its excessive accumulation in them. Glutamine has 
been shown to increase mitochondrial permeability [27]. 
Ammonia itself does not induce mitochondrial swelling, 
even though it increases glutamate uptake in mitochondria 
[18].
It has been demonstrated that activation of the neu-
ronal NKCC1 (Na+− K+ 2Cl−-cotransporter, encoded by 
the SLC12A2 gene) is involved in the astrocyte swelling 
induced by ammonia and in brain edema [28]. Preclin cal 
results in non-anesthetized mouse model of childhood epi-
lepsy (ornithine transcarbamylase-deficient mice), which 
are contradictory to earlier conceptions as to the critical role 
of astrocyte swelling, have recently been published. Accord-
ing to them an acute increase in extracellular ammonia does 
not lead primarily to astrocyte swelling but rather to unbal-
anced astrocyte buffering of potassium ions, with increases 
extracellular potassium overactivating the NKCC1, which 
in turn compromises inhibitory neurotransmission in the 
cerebral cortex and depolarizes the neuronal GABA reversal 
potential (EGABA ) [29 ]. Consequently, intracellular chloride 
is increased in neurons and the main fast-acting inhibitory 
system, GABAA receptor-mediated inhibition, is blunted, 
leading to a myoclonic seizure phenotype in this mouse 
model. This abnormal GABAergic excitation might be exac-
erbated by the known increase in extracellular GABA due to 
ammonia-induced inhibition of GABA uptake and enhance-
ment of GABA release [17], and by increased synthesis of 
GABA by glutamate decarboxylase due to increased glu-
tamate levels [30]. The potassium uptake mechanisms by 
Na+/K +-ATPase are then saturated by increased ammonium 
ion levels. According to these studies increased ammonia 
would thus seem not to lead to astrocyte swelling but rather 
to transient astrocyte shrinking. Astrocyte swelling or brain 
edema only occurs in the terminal stages of ammonia toxic-
ity [31]. Importantly, the clinically used diuretic inhibitor 
of NKCC1, bumetanide, has been seen to block the effects 
of acute ammonia on GABAergic neurotransmission and 
prevent seizures in the mouse model [29]. I  re ains t  be
established whether these acute mechanisms show adapta-
tion during more modest and prolonged hyperammonemia.
Molecular Mechanisms Involved
At present, several factors and pathways have been surmised 
to be associated in ammonia toxicity [32]. To date, hese 
include oxidative and nitrosative stress [9 , 33], adverse 
alterations in the glutamate-glutamine cycle, changes in 
mitochondrial permeability transition (MPT) [34], effects 
on neural transmission, activation of mitogen-activated 
protein kinases (MAPKs) and effects on the transcription 
factor nuclear factor-kappa B (NF-κB) [35]. Such effects 
N-methyl-d-aspartate (NMDA) receptor functions [7]. The 
disruption of energy metabol sm by ammonia and distur-
bances in axonal growth during development ould also be 
factors contributing to mental retardation [8].
Increased accumulation of ammonia in the brain due to 
liver dysfunction is a major factor in the pathogenesis of 
hepatic encephalopathy [9]. Hyper mmonemia apparently 
affects brain functions by several mechanisms. It blocks 
chloride efflux from postsynaptic neurons [10 ], causes
depression of synaptic transmission [11], inhibits neuron-
astrocyte trafficking of glutamate and affects postsynap-
tic glutamate receptors [12]. The firing of glutamatergic 
neurons in the CA1 region of th hippocampus evoked by 
applied glutamate is then abolished by ammon a. On the 
other hand, glutamate exocytosis is evoked by ammonia 
in cultured rat astrocytes [13]. Ammonia also affects other 
neurotransmitter systems in ad ition to the glutamatergic. 
The synthesis of histamine, serotonin, dopamine and nor-
adrenaline in the brain is altered by hyperammonemia [14]. 
For example, ammonium chloride directly admi istered to 
the rat striatum via reversed microdialysis evokes a prompt 
accumulation of dopamine in the microd alysates [15]. 
Furthermore, ammonia influences the passage of different 
molecules across the blood–brain barrier. It modulates th  
transcellular passage of low- to medium-size molecules by 
affecting their carriers located at this barrier [16]. Ammoni  
also inhibits GABA uptake and enhances its release [17]. 
On the other hand, ammonia has been shown to stimulate 
glutamine uptake into non-synaptic mitochondria iso t d 
from rat cerebral hemispheres [18]. We here briefly review 
these proposed mechanisms.
Astrocyte Swelling and Shrinking
Ammonia induces astrocytic swelling [19 ]. Astrocyte swell-
ing is believed to be a key component i  the cytotoxic 
brain edema [20] associated with acute liv r failure and the 
increase in intracranial pressure and eventually br  her-
niation which is often the cause of deat  in pa i nts wi h 
hepatic encephalopathy [21]. Elevated ammonia has also 
been shown to produce astrocytic swelling, tissue swelling 
and neuronal toxicity in organotypic slice cultures of cere-
bral tissue [22]. Astrocyte swelling has th s been generally 
assumed to be the key factor in the generation of ammonia 
toxicity and the increase in intracranial pressure le ding o 
brain herniation and death [19 , 23].
Glutamine has been thought to be the principal facto  in 
ammonia detoxification. More recently, however, glutamine 
has been considered to mediate ammonia toxicity when in 
excess [24, 25]. In keeping with this assumption the cerebral 
glutamine content has been shown to corr late positively 
with the grade of hepatic en eph lop thy [26]. Glutamine 
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bioenergetics and oxidative stress appear to be critical fac-
tors in this pathogenesis [52]. MPT seems thus to represent 
an important component in the pathogenesis of hepatic 
encephalopathy and other hyperammonemic states [53]. In 
line with these speculations, direct application of glutamine 
to cultured astrocytes increases free radical production and 
induces MPT [54]. Only astrocytes, but not neurons, gener-
ate free radicals following glutamine exposure [55].
Brain glucose consumption is diminished in portacaval 
shunt-induced [56] and thioacetamide-induced [57] hyper-
ammonemic states. Hyperammonemia can induce cere-
bral energy failure by several mechanisms [58, 59 ]. Th  
high concentration of ammonia interferes with oxidative 
metabolism in the brain through an inhibitory effect on the 
tricarboxylic acid cycle [60 ]. Ammonia also induces ATP 
depletion due to activation of Na+/K +-ATPase, which, in 
turn, is a consequence of decreased phosphorylation by pro-
tein kinase C (PKC) [61]. Ammonium chloride also affects 
energy metabolism by increasing the neuronal tricarboxylic 
acid cycle activity and switching it in astrocytes towards 
glutamine synthesis [62]. At var ance with this assumption 
the excess ammonia has been reported to interfere with brain 
energy metabolism by inhibiting the tricarboxylic acid cycle 
and this inhibition may result in depletion of ATP in the 
brain cells [63]. Moreover, there are also other controversial 
findings on this topic. It has been consistently reported that 
hepatic encephalopathy and concomitant hyperammonemia 
lead to reduced cerebral oxygen consumption. However, 
this may not be directly linked to an effect of ammonia but 
related to the fact that hepatic encephalopathy is always 
associated with reduced brain activity [64]. Th  whole-brain 
oxidative metabolism in patients with hepatic encephalop-
athy may not be due to malfunction of oxidative metabo-
lism in astrocytes. The observed decline of brain oxidative 
metabolism may result from changes in neurons and their 
energy turnover [65].
One of the primary roles of astrocytes is to protect neu-
rons against excitotoxicity by taking up excess ammonia 
and glutamate and converting them into glutamine via glu-
tamine synthetase, which is located almost exclusively in 
astrocytes [66 , 67]. Changes in the expression of this enzyme 
reflect changes in astroglial functions, hence also affecting 
neuronal functions [68]. Newly synthesized glutamine is 
transferred to neurons and hydrolyzed by glutaminase to 
glutamate [30]. In hepatic encephalopathy the expression of 
glutamate transporter (EEAT-2) is decreased, which impairs 
the cycling of glutamate-glutamine between astrocytes and 
neurons. Consequently, extracellular level of the main fast-
acting excitatory neurotransmitter glutamate is increased, 
the NMDA receptor-mediated signaling activated, includ-
ing RNS production, and tyrosine residues are nitrated. This 
sequence of events has been considered a cornerstone in the 
pathogenesis of hepatic encephalopathy [69 ].
strongly suggest the involvem t of phosphorylation of 
MAPKs in the mechanism of ammonia- duced astrocyte 
dysfunction associated with am onia eur toxici y [36]. 
Blockade of the MPT, MAPKs and NF-κB has been shown 
to reduce the extent of astrocyte swelling [35]. The cyto-
plasmic level of tumor suppressor phosphoprotein p53 is 
also increased in acute tox city with large ammonium doses 
[37, 38]. These above effectors generat ad tional reactive 
oxygen–nitrogen species, phosphorylate vario s pr te ns 
and transcription factors, and cause mitochondrial dysfunc-
tion. Astrocytes exposed to ia al o exhibit a reduc-
tion in intra- and extracellular l vels of th ombospondin-1, 
an astrocytic factor involved in the main enance of synap-
tic integrity. A defective rele se of thrombospondin-1 may 
impair synaptic integrity in chronic hepatic encephalopathy 
[39 ].
Ammonia markedly enhances he generation of reactive 
oxygen and nitrogen species (ROS and RNS), includ ng t e 
highly toxic peroxynitrite, in astrocytes [40, 41]. The pro-
duction of hydroxyl radicals s also in reased in vivo in the 
rat striatum upon microdialysis of ammo ium chloride [42]. 
The generation of reactive oxyg n and nitrogen speci s, in 
turn, induces protein tyrosi  nitra ion [43], lipid perox da-
tion [44], S-nitrosylation of cysteine residues n protein , 
and nucleic acid oxidation [45]. Glutathione is the major 
antioxidant in the brain and c uld ounteract the rmful 
effects of reactive oxygen and nitrogen species. The synthe-
sis of glutathione in cultur d astrocytes [46] and the upt ke
of its precursor cysteine [47] a e fom nt d by a monia. 
In line with these observations, the glutathione cont nt is 
increased in the brain extr cellular spaces after administra-
tion of ammonium chloride [48].
Elevated concentrations of ammonia induce the forma-
tion of free radicals in astrocytes, whi h is associated with 
the synthesis of glutamine [40]. When the glutamine trans-
port into cultured astrocytes is prevent d, the generation of 
ammonia-induced reactive oxygen species production, cell 
swelling, MPT, and loss of ATP a e completely blocked or 
significantly attenuated [49 ]. These findings clearly impli-
cate mitochondrial glutamine tran port in the me anism 
of ammonia neurotoxicity. It has been proposed that th  
glutamine-derived ammonia withi  mi chondria interferes 
with mitochondrial functio s, giving rise to excessive pro-
duction of free radicals and induction of MPT, two phenom-
ena which bring about astrocyte dysfunction, including cell 
swelling [50]. Glutamine thus induces oxidative stress and 
MPT, being critical in the development of astrocyte swe l-
ing in hyperammonemia [23].
There is strong evidence to indicate th  oxidative stress 
is involved in the induction of MPT by amm nia, and that 
oxidative stress and the subsequent induction of MPT 
contribute to the pathogenesis of hepatic encephalopathy 
and other hyperammonemic disorders [51, 52]. Altered 
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citrulline levels could be regulated by both NMDAR and 
GABA A R activities, and importantly, the neurosteroid sen-
sitivities of both receptor systems were altered depending on 
the increased ammonium levels. Several neurosteroids, for 
example allopregnanolone, tetrahydrodeoxycorticosterone 
and dehydroepiandrosterone sulphate, reduced the pathway, 
whereas pregnenolone sulphate enhanced it. The results 
were taken to indicate that certain neurosteroids might con-
tribute to cognitive symptoms of hyperammonemia while 
others alleviate them [82, 83]. In line, Zorumski et al. [84, 
85] have reported that 100 μM ammonium in vitro inhibits 
the induction of NMDAR-dependent long-term potentiation 
(LTP) via increased neurosteroid synthesis in hippocampal 
slices. The effect of ammonium could be blocked by fin-
asteride, a selective inhibitor of 5α-reductase needed for 
neurosteroid synthesis, and by GABAA R blocker picro-
toxin, as well as by l-carnitine. The key step in the neuros-
teroid synthesis is mediated by the mitochondrial 18 kD  
translocator protein (TSPO, formerly known as peripheral 
benzodiazepine receptor), which enhances the uptake of the 
precursor cholesterol for the synthesis [86]. The TSPO is 
strongly upregulated in animal models of hyperammonemia 
and in patients with hepatic encephalopathy [87–91 ], which 
then increases neurosteroid levels [92 , 93 ]. These nterest-
ing observations await for translation to clinical trials, par-
ticularly as finasteride has alleviated various symptoms in 
a model of thioacetamide-induced hepatic encephalopathy 
in rats [94].
How to Alleviate Ammonia Toxicity? Preclinical 
vs. Clinical?
The severity of symptoms in ammonia toxicology has 
been the impetus in the search for methods and com-
pounds which could alleviate them, in addition to pos-
sible neurosteroid-related mechanisms (see above). Some 
Involvement of N-me hyl-d-aspartate Receptors
Ionotropic NMDA receptors are involved in many functions 
in the central nervous system. The severity of the symptoms 
caused by hyperammonemia is positively correlated with the 
activation of NMDA receptors [70]. The acute neurotoxic 
effects of ammonia may thus be due mainly to overactiva-
tion of NMDA receptors, possibly potentiated by impaired 
control of their function by metabotropic glutamate recep-
tors [71]. The sequence of events consists of increased 
extracellular glutamate stimulating NMDA receptors, which 
leads to increased intracellular Ca2+ and subsequent activa-
tion of NADPH oxidase (superoxide production, ROS) and 
NO synthase (NO production, RNS). Superoxide and NO 
can then promote the formation of peroxynitrite and protein 
tyrosine nitration. On the other hand, long-term exposure to 
ammonia of cultured cerebellar neurons impairs the gluta-
mate-NO pathway in a dose- and time-dependent manner. 
The glutamate-induced formation of cGMP is reduced with-
out effects on NO synthase [72].
The ammonia-induced swelling of rat cerebral corti-
cal slices is significantly attenuated by NMDA receptor 
antagonists, inhibitors of t  NO synthase, and taurine [73].
Ammonia treatment in vivo reduces synthes s of kynurenic 
acid, which is an endogenous, broad-spe trum antagonist of 
ionotropic glutamate receptors [74]. Inhibition f xcitatory
synaptic transmission by elevated brain mon a has been 
assumed to underlie the cen ral ervous system depression 
in hepatic encephalopathy [75]. Ammonia ma stimul te th  
expression of inducible NO synt ase in astrocytes, leading 
to excessive formation of NO, which i  turn could trigger 
the formation of peroxynitrite in adjacent euron i ucing 
their death [76]. The NMDA receptor antag n st dizocilpine 
(MK-801) blocks the ammonia-induced generation of reac-
tive oxygen and nitrogen specie  in astrocytes [77]. On the 
other hand, administration of ammonium chloride has been 
reported to reduce the expression f tw  NMDA r ceptor 
subunits (GluN2A and GluN2B) in he rat hippocampus
[78]. Ammonium chloride infusion to h  rat s riatum n
vivo via a microdialysis probe gl tamin , NO
oxidation products and cGMP  the microdialysate [79].
Likewise, it activates NMDA re eptor  and foment  the 
generation of hydroxyl radicals [42]. Ammonia also induces
apoptosis as a result of a complex interplay of at least three 
signalling molecules: NO, PKC and NF-κB. The NF-κB is 
possibly involved in the induction of iNOS and the genera-
tion of toxic levels of NO in C6 glioma c lls [80]. Figure 1 
summarizes the main sequelae of ammonia neurotoxicity.
More recently, Cauli et al. [81, see for refs] have used 
cerebellar in vivo microdialysis to assess the mechanisms of 
ammonium-induced impairment of the glutamate-NMDAR-
NO-cGMP pathway. NMDA-triggered citrulline and cGMP 
production was monitored in dialysate . The cGMP and 
Fig. 1Main factors responsible for hepatic encephalopathy, the most 
severe form of neurotoxicity induced by hyperammonemia
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Concluding Remark
Rapid advances in knowledge of the mechanisms involved 
in hyperammonemia-induced alterations in the brain are the 
basis for an understanding of the neurochemical, cellular, 
functional and structural effects caused by ammonia, hope-
fully leading to the invention of novel strategies in the treat-
ment of hepatic encephalopathy.
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